The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Endeavour Silver Corporation

Related Interviews

Four Reasons to Be Bullish on Gold
November 30, 2023
Reichman, Mark L.

Investing in Attractively Valued Gold Equities
November 29, 2019
Bryan, Caesar M.P., Mancini, Chris

Interview with the CEO: Endeavour Silver Corp. (NYSE:EXK)
November 30, 2018
Cooke, Bradford

Interview with the CEO: Endeavour Silver Corp. (NYSE:EXK)
December 08, 2017
Cooke, Bradford

Interview with the CEO: Endeavour Silver Corp. (NYSE:EXK)
December 09, 2016
Cooke, Bradford

Interview with the Founder and CEO: Endeavour Silver Corp. (NYSE:EXK)
December 11, 2015
Cooke, Bradford

Interview with the Founder and CEO: Endeavour Silver Corp. (EXK)
November 04, 2014

Interview with the Founder and CEO: Endeavour Silver Corp. (EXK)
April 09, 2014

Seabridge Gold Inc. - Rudi P. Fronk
December 19, 2011

Silver Falcon Mining, Inc. - Pierre Quilliam
December 20, 2010

Weingarten Realty Investors - Andrew M. Alexander
February 08, 2010

Cart

Latest News

Contrarian Investing in Biotechs and Medical Device Stocks
Bear Market Investing: Is There a Way to Profit During Tariff Turmoil?
Tariff Beating US Defense and Aerospace Stocks from Morningstar: “They Don’t Usually Get this Cheap”

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Using Value-to-Price Analysis to Rotate Into Undervalued Industries

Craig Callahan
Scott Callahan

Published May 15, 2025 in Defensive Investing Strategies

Companies covered: VOD TMUS EVRG AEP

Buy ($25)

Small Cap Value Strategy Seeks Defensive Characteristics Backed by Catalysts

Yolanda Foreman
Justin Wallace

Published May 15, 2025 in Defensive Investing Strategies

Companies covered: ATGE SKYW LYTS

Buy ($25)

Utilities Show Resilience in Face of Recession and Tariff Fears

Timothy Winter

Published May 15, 2025 in Defensive Investing Strategies

Companies covered: WEC MSFT LNT SO ACA XYL SWX NFG PPL EIX PCG CEG VST HUBB TXMN CTRI

Buy ($25)

Most Popular Reports

Defensive Investing Strategies

Published May 15, 2025

Topics covered: Defensive Investing Strategies

Buy ($175)

Biotechnology, Pharmaceuticals and Medical Devices

Published April 29, 2025

Topics covered: Biotechnology Pharmaceuticals Medical Devices

Buy ($175)

Dividend-Oriented Strategies

Published April 10, 2025

Topics covered: Dividend-Oriented Strategies

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)
Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)
Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Using Value-to-Price Analysis to Rotate Into Undervalued Industries
Small Cap Value Strategy Seeks Defensive Characteristics Backed by Catalysts
Utilities Show Resilience in Face of Recession and Tariff Fears
ANALYST INTERVIEWS
Small Cap Med-Tech Names Are More Insulated from Tariff Fallout
Penumbra and AngioDynamics Among Top Med-Tech Sector Picks
Onshoring Drug Manufacturing Is Critical, But Not Easy
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2025
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google